Pemoline for Cocaine Abuse - 7

This study has been completed.
Sponsor:
Collaborators:
National Institute on Drug Abuse (NIDA)
VA Connecticut Healthcare System
Information provided by (Responsible Party):
Yale University
ClinicalTrials.gov Identifier:
NCT00000282
First received: September 20, 1999
Last updated: July 24, 2013
Last verified: December 2002
  Purpose
The purpose of this study is to evaluate the treatment of pemoline for cocaine abuse.

Condition Intervention Phase
Cocaine-Related Disorders
Drug: Pemoline
Phase 2

Study Type: Interventional
Study Design: Primary Purpose: Treatment
Official Title: Pemoline for Cocaine Abuse

Resource links provided by NLM:


Further study details as provided by Yale University:

Primary Outcome Measures:
  • Side effects
  • Drug use
  • Retention

Estimated Enrollment: 0
Study Start Date: September 1994
Study Completion Date: August 1999
Primary Completion Date: August 1999 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
Please contact site for information.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000282

Locations
United States, Connecticut
VA Connecticut Healthcare System
New Haven, Connecticut, United States, 06519
Sponsors and Collaborators
Yale University
National Institute on Drug Abuse (NIDA)
VA Connecticut Healthcare System
Investigators
Principal Investigator: Thomas R Kosten, M.D. VA Connecticut Healthcare System
  More Information

Publications:
J Psychoactive Drugs 28:301-304, 1996. Addictive Beh. 22, 1997. Am J Addiction 5, 275, 1996.

Responsible Party: Yale University
ClinicalTrials.gov Identifier: NCT00000282     History of Changes
Other Study ID Numbers: NIDA-09250-7  P50DA009250  P50-09250-7 
Study First Received: September 20, 1999
Last Updated: July 24, 2013
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Cocaine-Related Disorders
Substance-Related Disorders
Chemically-Induced Disorders
Mental Disorders
Cocaine
Pemoline
Anesthetics, Local
Anesthetics
Central Nervous System Depressants
Physiological Effects of Drugs
Sensory System Agents
Peripheral Nervous System Agents
Vasoconstrictor Agents
Dopamine Uptake Inhibitors
Neurotransmitter Uptake Inhibitors
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Dopamine Agents
Neurotransmitter Agents
Central Nervous System Stimulants

ClinicalTrials.gov processed this record on July 26, 2016